Biblio
2024
Ueki H, Ogawa C, Goto H, Nishi M, Yamanaka J, Mochizuki S, Nishikawa T, Kumamoto T, Nishiuchi R, Kikuta A, et al. TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia. Int J Hematol. 2024.
2023
Imai C, Sato A, Hiwatari M, Shimomura Y, Hori T, Suenobu S, Imamura T, Hara J, Hasegawa D, Takahashi H, et al. Outcomes following induction failure in Japanese children with acute lymphoblastic leukemia. Int J Hematol. 2023.
2021
Takachi T, Watanabe T, Miyamura T, Saito A, Deguchi T, Hori T, Yamada T, Ohmori S, Haba M, Aoki Y, et al. Hematopoietic stem cell transplantation for infants with high-risk KMT2A gene rearranged acute lymphoblastic leukemia. Blood Adv. 2021.